NMDA antagonist properties of the putative antiaddictive drug, ibogaine.

Piotr Popik, Richard T. Layer, Linda H. Fossom, Morris Benveniste, Beth Geter-douglass, Jeffrey M. Witkin, P. Skolnick

Journal of Pharmacology and Experimental Therapeutics November 1, 1995 Peer reviewed DOI: 10.1016/s0022-3565(25)12125-3 via OpenAlex

Relevant Not relevant

Abstract

No abstract available from the source.

Tags

Nmda receptor Pharmacology Dizocilpine Antagonist +-naloxone

Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-d-aspartate receptors Progress in Neuro-Psychopharmacology and Biological Psychiatry • June 21, 2003 • via OpenAlex
Chapter 3 Ibogaine as a glutamate antagonist: Relevance to its putative antiaddictive properties The Alkaloids. Chemistry and biology/The alkaloids. Chemistry and biology • January 1, 2001 • via OpenAlex
The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex Psychopharmacology • May 1, 1994 • via OpenAlex
Involvement of NMDA glutamate receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA Behavioural Pharmacology • May 14, 2015 • via OpenAlex
BDNF Release Is Required for the Behavioral Actions of Ketamine The International Journal of Neuropsychopharmacology • October 31, 2014 • via OpenAlex

Comments

No comments yet.

Log in to comment